Cargando…
Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
Diabetic nephropathy (DN) is one of the most important complications of diabetes, and the leading cause of end-stage renal disease (ESRD). While Chromium picolinate (CrPic) supplementation has been found to be effective in treating diabetes, its effects on diabetic-induced nephropathy have not been...
Autores principales: | Qi, Shan Shan, Zheng, Hong Xing, Jiang, Hai, Yuan, Li Ping, Dong, Le Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175215/ https://www.ncbi.nlm.nih.gov/pubmed/32143429 http://dx.doi.org/10.3390/biom10030398 |
Ejemplares similares
-
Chromium picolinate and chromium histidinate protects against renal dysfunction by modulation of NF-κB pathway in high-fat diet fed and Streptozotocin-induced diabetic rats
por: Selcuk, Mustafa Yavuz, et al.
Publicado: (2012) -
Genistein attenuates renal fibrosis in streptozotocin-induced diabetic rats
por: Jia, Qiang, et al.
Publicado: (2019) -
Dendropanax morbifera Protects against Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
por: Sachan, Richa, et al.
Publicado: (2020) -
The Effect of Chromium Picolinate Supplementation on the Pancreas and Macroangiopathy in Type II Diabetes Mellitus Rats
por: Huang, Shan, et al.
Publicado: (2014) -
Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes
por: Golubnitschaja, Olga, et al.
Publicado: (2014)